|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current assets | |||||||||
| Prepaid insurance | |||||||||
| Cash | |||||||||
| Due from Everli | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Long-term prepaid insurance | |||||||||
| Marketable securities and cash held in Trust Account | |||||||||
| TOTAL ASSETS | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued liabilities | |||||||||
| Due to Sponsor | |||||||||
| Over-allotment option liability | |||||||||
| Working Capital Loan - related party | |||||||||
| Sponsor Loan | |||||||||
| Total current liabilities | |||||||||
| Deferred underwriting fee | |||||||||
| Deferred Fee | |||||||||
| TOTAL LIABILITIES | |||||||||
| Class A Ordinary Shares subject to possible redemption, 3,923,923 and 16,000,000 shares at redemption value of $10.93 and $10.71 per share at June 30, 2026 and December 31, 2025, respectively | |||||||||
| Class A Ordinary Shares | |||||||||
| Class A ordinary shares subject to possible redemption | |||||||||
| Total class A Ordinary Shares | |||||||||
| Total class A Ordinary Shares subject to possible redemption, 3,923,923 and 16,000,000 shares at redemption value of $10.93 and $10.71 per share at June 30, 2026 and December 31, 2025, respectively | |||||||||
| SHAREHOLDERS’ DEFICIT | |||||||||
| Ordinary shares, value | |||||||||
| Accumulated deficit | |||||||||
| TOTAL SHAREHOLDERS’ DEFICIT | |||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
